Statistical methods for assessing the influence of study characteristics on treatment effects in 'meta-epidemiological' research

Statistics in Medicine

Volumn 21, Issue 11, 2002, Pages 1513-1524

  Sterne, Jonathan A C ^a,e   Jüni, Peter ^b   Schulz, Kenneth F ^c   Altman, Douglas G ^d   Bartlett, Christopher ^a   Egger, Matthias ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF BERN   (Switzerland)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e Canynge Hall ^*  (United Kingdom)

Author keywords

Clinical trials; Language bias; Meta analysis; Publication bias; Trial quality

Indexed keywords

ANALYTICAL ERROR; ARTICLE; CLINICAL TRIAL; CLUSTER ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; EPIDEMIOLOGY; HUMAN; LANGUAGE; LOGISTIC REGRESSION ANALYSIS; MEDICAL RESEARCH; META ANALYSIS; OUTCOMES RESEARCH; PUBLICATION; QUALITY CONTROL; REVIEW; STANDARD; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

BIAS (EPIDEMIOLOGY); EPIDEMIOLOGIC METHODS; HUMANS; LOGISTIC MODELS; META-ANALYSIS; RESEARCH DESIGN; STATISTICS; TREATMENT OUTCOME;

EID: 0037098203     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/sim.1184     Document Type: Article

References (28)

1. Problems and limitations in conducting systematic reviews
2. Publication bias in clinical research
3. Factors influencing publication of research results: Follow-up of applications submitted to two institutional review boards
4. Publication bias: Evidence of delayed publication in a cohort study of clinical research projects
5. Language bias in randomised controlled trials published in English and German
6. Cholesterol lowering trials in coronary heart disease: Frequency of citation and outcome
7. Impact of covert duplicate publication on meta-analysis: A case study
8. Multiple publication of reports of drug trials
9. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials
10. Assessing the quality of controlled clinical trials
11. Beta blockade during and after myocardial infarction: An overview of the randomized trials
12. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?
13. Does the inclusion of grey literature influence estimates of intervention effectiveness reported in meta-analyses?
14. The behaviour of maximum likelihood estimates under non-standard conditions
15. Heteroskedasticity-consistent covariance matrix estimator and a direct test for heteroskedasticity
16. sg17: Regression standard errors in clustered samples
17. Some aspects of the design and analysis of cluster randomization trials
18. Meta-analysis in clinical trials
19. A random-effects regression model for meta-analysis
20. Explaining heterogeneity in meta-analysis: A comparison of methods
21. Publication and related bias in meta-analysis: Power of statistical tests and prevalence in the literature
22. Improving the quality of reporting of randomized controlled trials. The CONSORT statement
23. The revised CONSORT statement for reporting randomized trials: Explanation and elaboration
24. What contributions do languages other than English make on the results of meta-analyses?
25. A multilevel model framework for meta-analysis of clinical trials with binary outcomes
26. Direction and impact of language bias in meta-analyses of controlled trials: Empirical study
27. The unpredictability paradox: Review of empirical comparisons of randomised and non-randomised clinical trials